Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)–Infected Individuals Without HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study
Author(s) -
Davi Tanajura,
Néviton Castro,
Paulo Oliveira,
Abraão Neto,
André Muniz,
Natália B. Carvalho,
Glória Orge,
Silvane Santos,
Marshall J. Glesby,
Edgar M. Carvalho
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ229
Subject(s) - medicine , tropical spastic paraparesis , myelopathy , incidence (geometry) , hyperreflexia , cohort , cumulative incidence , human t lymphotropic virus , pediatrics , cohort study , peripheral neuropathy , surgery , spinal cord , physics , psychiatry , optics , diabetes mellitus , endocrinology
Human T-cell lymphotropic virus type 1 (HTLV-1) is the agent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of infected individuals. Despite low prevalence, many HTLV-1-infected patients who do not fulfill criteria for HAM/TSP present with neurological complaints related to sensory, motor, urinary, or autonomic manifestations. The aim of this study was to determine the incidence of neurologic manifestations and risk factors associated with these outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom